Bionano Genomics, Inc (BNGO)

Etorro trading 970x250
Bionano Genomics, Inc (BNGO) Logo

About Bionano Genomics, Inc

Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets, and to streamline the study of changes in chromosomes, which is known as cytogenetics. Its Saphyr system includes an instrument, chip consumables, reagents, and a suite of data analysis tools. The company’s Bionano prep kits and labeling kits provide the critical reagents and protocols needed to extract and label high molecular weight DNA for use with the Saphyr system; and data solutions offering includes a suite of hardware and software for end-to-end experiment management, algorithms for assembling genome maps, and algorithms and databases for bioinformatics processing. It sells its products for research use applications primarily to laboratories associated with academic and governmental research institutions, as well as to pharmaceutical, biotechnology, and contract research companies in the United States and Canada, Europe, the Middle East, India, Africa, China, Japan, South Korea, Singapore, and Australia. The company was formerly known as BioNano Genomics, Inc. and changed its name to Bionano Genomics, Inc. in July 2018. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California. Address: 9540 Towne Centre Drive, San Diego, CA, United States, 92121

Bionano Genomics, Inc News and around…

Latest news about Bionano Genomics, Inc (BNGO) common stock and company :

Presentation at ASHG Showcases New Capabilities for Optical Genome Mapping with Detection of Allelic Imbalance and Absence of Heterozygosity Further Expanding Its Utility in Revealing More Clinically Relevant Variants
20 Oct, 2021 Yahoo! Finance

SAN DIEGO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), developer of the Saphyr® system that uses optical genome mapping (OGM) for the detection and analysis of structural variants (SVs), today announced that Bionano scientists presented a poster at the American Society of Human Genetics (ASHG) conference that showcased new capabilities for OGM on the Saphyr® system with detection of allelic imbalance and absence of heterozygosity (AOH), which further expands its utility in r

Jim Cramer Prefers This Stock Over Mogo, Considers Endeavor Group As Inexpensive
19 Oct, 2021 FinancialContent

On CNBC’s "Mad Money Lightning Round," Jim Cramer saidhe prefers Intuit Inc. (NASDAQ: INTU) over Mogo Inc. ...

Bionano Genomics’ Latest Software Business Acquisition Adds Immense Value
19 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips BNGO stock isn't a darling of the markets at the moment, but Bionano continues to advance its stature in the optical genome mapping niche. The post Bionano Genomics’ Latest Software Business Acquisition Adds Immense Value appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Bionano Genomics Stock Looks Ready to Reward Patient Investors
18 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips BNGO stock is down 25% since the beginning of the year. But as the company begins to deliver consistent revenue, a prudent investment may be rewarded. The post Bionano Genomics Stock Looks Ready to Reward Patient Investors appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Bionano Genomics Announces American Society of Human Genetics Presentations Featuring Optical Genome Mapping for Genetic Disease and Cancer Research Applications
15 Oct, 2021 Yahoo! Finance

SAN DIEGO, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), developer of the Saphyr® system that uses optical genome mapping (OGM) for the detection and analysis of structural variants (SVs), today announced the American Society of Human Genetics (ASHG) conference lineup of customer posters and presentations featuring OGM. The customer posters and presentations span genetic disease applications including amyotrophic lateral sclerosis (ALS) and postnatal, as well as cancer researc

Bionano: BioDiscovery Acquisition Further Bolsters the Bull Case, Says Oppenheimer
14 Oct, 2021 Yahoo! Finance

Bionano’s (BNGO) profile has grown considerably over the past year, mostly due to the disruptive potential of its genome mapping platform Saphyr. On Tuesday, the company announced it is further adding to its genome analysis capabilities with the acquisition of BioDiscovery, a software company with industry leading analysis tools. These include NxClinical, a software solution for variant analysis. The purchase will cost up to $100 million, consisting of a mix of cash and equity and should be comp

Study Shows the Combination of OGM and NGS with Linked-Reads Detects Significantly More Clinically Relevant Variants Resulting in Higher Success Rates for Resolving Previously Unclassified Subjects in Genetic Disease Research
14 Oct, 2021 Yahoo! Finance

SAN DIEGO, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), developer of the Saphyr® system that uses optical genome mapping (OGM) for the detection and analysis of structural variants (SVs), today announced the publication of a study in which OGM and next-generation sequencing (NGS) with linked-reads were used together to resolve genetic diseases that were previously unclassified after evaluation by whole-exome sequencing (WES) alone. This study, from the University of Californi

Bionano Genomics to Acquire BioDiscovery for $100M; Shares Rise 4.9%
13 Oct, 2021 Yahoo! Finance

Shares of genome analysis company Bionano Genomics, Inc. (BNGO) jumped 4.9% on Tuesday and closed at $5.40 in extended trade after the company announced that it signed a definitive agreement to acquire BioDiscovery, Inc., a genomics data-focused software company, for $100 million. The consideration will be paid in a combination of equity and cash. Bionano Genomics’ position in the market, as one of the foremost players in digital cytogenetics and comprehensive genome analysis, is expected to fur

DNA Stock: The Bull Call That Has Ginkgo Bioworks Bouncing Back After Last Week’s “Scam” Accusation
12 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ginkgo Bioworks (DNA) stock is doing well on Tuesday as it recovers with new coverage from an analyst with a bull stance. The post DNA Stock: The Bull Call That Has Ginkgo Bioworks Bouncing Back After Last Week’s “Scam” Accusation appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

What's Up With Bionano Genomics Today?
12 Oct, 2021 FinancialContent

Bionano Genomics Inc. (NASDAQ: BNGO) shares are trading higher Tuesday after the company announced it agreed to buy BioDiscovery Inc, a ...

BNGO Stock: The Big Acquisition News Sending Bionano Genomics Soaring
12 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bionano has just made a deal that will help it secure a spot among biotech companies riding the wave of the current boom. BNGO stock is up. The post BNGO Stock: The Big Acquisition News Sending Bionano Genomics Soaring appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Bionano Genomics to Acquire BioDiscovery, Furthering Bionano’s Vision of Creating the Most Comprehensive Variant Analysis Platform in Genomics
12 Oct, 2021 Yahoo! Finance

Designed to accelerate the adoption of optical genome mapping (OGM) with the integration of BioDiscovery’s NxClinical software solution for variant analysis Adds a world-class team, software and bioinformatics capabilities to address a broad range of applications in cancer and genetic diseases Brings potential for significant new growth opportunities in life science research and the clinical setting upon launch of an advanced NxClinical solution that integrates OGM, next-generation sequencing (N

Bionano Genomics to Acquire BioDiscovery in $100m Deal
12 Oct, 2021 Yahoo! Finance

By Sam Boughedda

Groundbreaking Tech Makes Bionano Genomics Look Better Than Ever
07 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Off and on the price chart, Bionano Genomics could be the next big thing in genomics with multiple catalysts for BNGO stock. The post Groundbreaking Tech Makes Bionano Genomics Look Better Than Ever appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Bionano Genomics Expands Commercial Leadership Team to Accelerate Growth of Saphyr® and Bolster Customer Support and Experience Globally
06 Oct, 2021 Yahoo! Finance

SAN DIEGO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), developer of the Saphyr® system that uses optical genome mapping (OGM) for the detection and analysis of structural variants (SVs), today announced that the following individuals have joined the Company’s commercial leadership team to help accelerate the global growth of Saphyr and bolster customer support: Amanda Lettmann, Vice President of Global Customer Experience, Amanda Hernandez, Vice President of Global Sales Tra

Analysts Predict 17% Upside For The Holdings of VHT
01 Oct, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Health Care ETF (VHT), we found that the implied analyst target price for the ETF based upon its underlying holdings is $288.57 per unit.

BNGO Stock: What Is Driving Bionano Genomics Higher Today?
30 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in Bionano Genomics and BNGO stock are cheering some positive clinical trial data around optical genome mapping. The post BNGO Stock: What Is Driving Bionano Genomics Higher Today? appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Largest Clinical Research Study to Date Evaluating Optical Genome Mapping for Analysis of Facioscapulohumeral Muscular Dystrophy Showed Concordance with Southern Blot and Reduced Turnaround Time by 50
29 Sep, 2021 FinancialContent
Largest Clinical Research Study to Date Evaluating Optical Genome Mapping for Analysis of Facioscapulohumeral Muscular Dystrophy Showed Concordance with Southern Blot and Reduced Turnaround Time by 50% as Compared to the Traditional Workflow
29 Sep, 2021 Yahoo! Finance

SAN DIEGO, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced the publication of the largest clinical research study to date evaluating optical genome mapping (OGM) for facioscapulohumeral muscular dystrophy (FSHD), which concluded that OGM can be performed more quickly, accurately, and reproducibly than the current gold standard method of Southern blot analysis. This study, now available online before print in The Journal of Molecular Diagnostics, describes how OGM

5 Ultra-Popular Stocks With 120% to 190% Upside, According to Wall Street
29 Sep, 2021 FinancialContent

Analysts' loftiest price targets portend significant upside for these widely owned (and followed) stocks.

3 Top Tech Stocks to Buy on Weakness
21 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips All three of these tech names, driven by very strong positive catalysts, should rally over the longer term, leading to high profits for investors. The post 3 Top Tech Stocks to Buy on Weakness appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Bionano Genomics Remains Promising With Global Product Adoption
21 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips BNGO stock has been stuck in a range, but its next move should be to the upside based on Bionano's breakthrough genome mapping system. The post Bionano Genomics Remains Promising With Global Product Adoption appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Study Finds the Combination of Optical Genome Mapping and Short-Read Sequencing Provides a Comprehensive Genome Analysis for Lung Cancer Samples and Enables the Discovery of New Biomarkers
16 Sep, 2021 FinancialContent
4 Small-Cap Growth Stocks Expected to Increase Sales 707% to 9,406% by 2024
16 Sep, 2021 FinancialContent

These under-the-radar companies are expected to deliver jaw-dropping revenue growth over the next four years.

If You Invested $1,000 In BioNano Stock One Year Ago, Here's How Much You'd Have Now
09 Sep, 2021 FinancialContent

Investors who have owned stocks in the last year have generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) ...

NuProbe Global Adopts Bionano’s Saphyr® System to Develop Products in Reproductive Health and Oncology Applications
07 Sep, 2021 FinancialContent
Peek Under The Hood: KOMP Has 19% Upside
31 Aug, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR— S&P Kensho New Economies Composite ETF (KOMP), we found that the implied analyst target price for the ETF based upon its underlying holdings is $76.69 per unit.

The Price Is Right for BioNano Genomics Given Saphyr’s Potential
30 Aug, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips With its Saphyr system seeing adoption ramp up, the long-term growth potential for BNGO stock is considerable. The post The Price Is Right for BioNano Genomics Given Saphyr’s Potential appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Bionano Genomics Announces ESHG Lineup Featuring 11 Customer Presentations of OGM Data Spanning Three Major Clinical Research Areas of Application from 10 Institutions and Six Countries
26 Aug, 2021 FinancialContent
11 Biotech Stocks Popular On Reddit
19 Aug, 2021 Yahoo! Finance

In this article, we discuss the 11 biotech stocks popular on Reddit. If you want to skip our detailed analysis of these stocks, go directly to the 5 Biotech Stocks Popular On Reddit. Biotechnology is one of the fields in which Reddit investors take active interest amid an explosive growth potential of the biotech industry. According […]

Bionano Genomics, Inc (BNGO) is a NASDAQ Common Stock listed in , ,

970x250